Atlas Trials

Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

Clinical trial NCT04409132 · COMPLETED

Trial details

NCT number
NCT04409132
Sponsor
Rockwell Medical Technologies, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2020-06-25
Primary completion
2021-04-02
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.